日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia

在KMT2A重排的急性B淋巴细胞白血病中,Venetoclax通过BCL-2抑制有效清除肿瘤细胞

Richter, Anna; Lange, Sandra; Holz, Clemens; Brock, Luisa; Freitag, Thomas; Sekora, Anett; Knuebel, Gudrun; Krohn, Saskia; Schwarz, Rico; Hinz, Burkhard; Murua Escobar, Hugo; Junghanss, Christian

Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.

泛AKT抑制剂MK-2206与BCL-2拮抗剂Venetoclax联合应用于B细胞前体急性淋巴细胞白血病

Richter Anna, Fischer Elisabeth, Holz Clemens, Schulze Julia, Lange Sandra, Sekora Anett, Knuebel Gudrun, Henze Larissa, Roolf Catrin, Murua Escobar Hugo, Junghanss Christian